Connect to other sites within the UBM Medica Network
Four questions for you to answer, four facts you need to know.
GLP-1 Agonist Pop Quiz
Take a short break from the clinic and try 2 quick questions about the injectable gut hormone analogs.
3 Weighty Questions About Obesity and Diabetes
Questions you were afraid to ask about weight-loss modalities in the context of obesity and type 2 diabetes are answered here.
Combo Diet-Exercise Programs Trim Diabetes Risk
In the diabetes news: diet and physical activity programs may help prevent type 2 DM, patiromer shows promise for hyperkalemia, metformin may treat portal hypertension.
GLP-1s May Do More Than Just Lower Glucose
A protective endothelial function effect may be seen with exenatide in patients who have long-standing type 2 diabetes in the postprandial period after short-term therapy.
3 Things You (Still) Need to Know About GLP-1 Agonists
Incretin mimetic therapy for type 2 diabetes has been on the market for more than 10 years. Find out what you've learned about the GLP-1 agonists, here.
Targeting Cell Aging May Yield Diabetes Therapy
Heading the diabetes news: therapeutic targeting of cellular senescence, food order affects glucose and insulin levels, sugar causes heart muscle damage, central obesity genetic score linked to type 2 DM risk.
Elevated Triglycerides in a Woman with Type 2 Diabetes
What do current guidelines recommend as first-line treatment for patients like 51-year-old TK? Check out these options.
Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes
The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.
Five Top Papers From 2014 That Will Impact Your Practice
New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.
By clicking Accept, you agree to become a member of the UBM Medica Community.